J0668 HCPCS Level II code: Instillation, bupivacaine and meloxicam, 1 mg/0.03 mg
J0668 is the HCPCS code for “Instillation, bupivacaine and meloxicam, 1 mg/0.03 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J0668Instillation, bupivacaine and meloxicam, 1 mg/0.03 mg
Short description: Instill, bupivac and meloxic
HCPCS · United States
Medicare details
The indicators CMS publishes with J0668 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care
- BETOS category
- Other drugs
- Added
- Oct 1, 2025
Where J0668 sits
- 1J codesDrugs administered other than orally
- 2Active code J0668Instillation, bupivacaine and meloxicam, 1 mg/0.03 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J0668 mean?
J0668 is the HCPCS code for “Instillation, bupivacaine and meloxicam, 1 mg/0.03 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J0668?
CMS lists J0668’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J0668
All J codesJ0650Injection, levothyroxine sodium, not otherwise specified, 10 mcgJ0651Injection, levothyroxine sodium (fresenius kabi), not therapeutically equivalent to j0650, 10 mcgJ0652Injection, levothyroxine sodium (hikma), not therapeutically equivalent to j0650, 10 mcgJ0654Injection, liothyronine, 1 mcgJ0665Injection, bupivicaine, not otherwise specified, 0.5 mgJ0666Injection, bupivacaine liposome, 1 mgJ0670Injection, mepivacaine hydrochloride, per 10 mlJ0675Injection, carboprost tromethamine, 0.1 mgJ0681Injection, ceftobiprole medocaril sodium, 3 mgJ0687Injection, cefazolin sodium (wg critical care), not therapeutically equivalent to j0690, 500 mgJ0688Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mgJ0689Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg